Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ethinylestradiol/chlormadinone - Grunenthal

Drug Profile

Ethinylestradiol/chlormadinone - Grunenthal

Alternative Names: Balianca; Belara; GRT4248

Latest Information Update: 25 Jan 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Grunenthal
  • Class Alkylated estrogenic steroids; Chlorinated steroids; Hormonal contraceptives; Hormonal replacements; Norpregnatrienes; Oral contraceptives
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Pregnancy
  • No development reported Acne

Most Recent Events

  • 05 Nov 2008 Grunenthal and FAES Farma agree to co-promote ethinylestradiol/chlormadinone in Spain for Contraception/Pregnancy (Prevention)
  • 13 Dec 2007 The Committee for Medicinal Products for Human Use recommends refusal of ethinylestradiol/chlormadinone for acne in women in the EU
  • 30 Jun 2006 Launched for Contraception/Pregnancy (Prevention) in Austria (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top